IL-33 signalling: An oncogenic or a tumour suppressor pathway in gastro-intestinal cancers? (#154)
Moritz F Eissmann
1
,
Frederik Masson
1
,
Christine Dijkstra
1
,
Matthias Ernst
1
- Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia